1. Cumulative working time: 6 years 154 days. Start date: 20 13-08-23.
2. At present, the total assets of the fund are 8265438+32 million yuan, which is the largest active fund management at present.
3. Currently, he manages 9 funds, and the best fund return during his tenure is 22 1. 14%.
4. Profile of the fund manager: Mr. Liu: Doctor of Economics, holding the qualification certificate of China Securities Investment Fund. He used to be a researcher and fund manager of China Post Venture Fund Management Co., Ltd., general manager and fund manager of equity investment department of Rongtong Fund Management Co., Ltd., researcher and deputy general manager of equity investment department of Guangfa Fund Management Co., Ltd., general manager of Beijing equity investment department, and fund manager of Guangfa Leading Hybrid Securities Investment Fund (2065 438+07-2065 438+09).
5. At present, he is the general manager of the Growth Investment Department of Guangfa Fund Management Co., Ltd., the fund manager of Guangfa Small and Medium-sized Growth Mixed Securities Investment Fund (LOF) (20 17, 19 to present), and the fund manager of Guangfa Innovation and Upgrade Flexible Allocation Mixed Securities Investment Fund (20 17 to present). Guangfa Xinxiang flexibly allocates fund managers of hybrid securities investment funds (from 20 165438+200710.9), and Guangfa Shuangqing upgraded the fund managers of hybrid securities investment funds (from 20 165438+200810.2). Fund Manager of Guangfa Diversified Emerging Stock Securities Investment Fund (20 1 18 years15 October to present), Fund Manager of Guangfa Unitalen Bond Securities Investment Fund (25 February18 to 23 July 2020), Fund Manager of Guangfa Technology Innovation Hybrid Securities Investment Fund (20)
Liu is famous for science and technology. After becoming famous, because of the surge in scale and more and more funds, he chose the relatively stable position of science and technology plate and medicine plate. Has continued to this day. Judging from the specific heavy stock positions of the six funds, the positions of these funds are basically similar, with little difference.
1, overall performance
Through the horizontal comparison, we found that the overall performance of the six funds managed by Liu was not very good. They were all green in the past 1 month, with a return of 9%- 14% in March and 13%-20% in the past six months.
2. The specific performance of a single fund
Since the positions of several funds have the same style, there is little difference in specific positions and the trend is basically the same, so I will not list them one by one. Let's choose Guangfa Small-cap Growth Mix with moderate performance in the past six months to see how it performs.
The performance of the stage increase is not very good, and the past week and January were very poor, almost at the end. Nearly March and June are average, and the rest are excellent.
The quarterly increase is still good, and the second quarter is still excellent, but it may be affected in the third quarter.
3. Trend analysis of single fund
Or the mixed growth of small-cap stocks, which is the trend of the fund in the past six months. We have seen that since the adjustment of medicine and science and technology in July, the performance of the fund has been more difficult, with two declines and two rises, followed by a long-term large-scale callback. In the end, the income in this half year is lower than the average level, which is basically equivalent to the income of the Shanghai and Shenzhen 300 Index in the same period.
The following contents are for reference only and do not constitute any investment advice.
1. Liu, the star fund manager of Guangfa Fund Company, manages a large number of funds, with a large overall fund scale and a large single fund scale. Although there is a strong investment and research team behind Guangfa Fund Company, it is not easy to maintain its operation.
2. Several representative funds managed by Liu, because they are catching up with the rising market of science and technology and encountering the outbreak of epidemic medicine, have outstanding performance in a certain period of time, and once dominated the income rankings at all stages, which is quite popular. With the stability of the domestic epidemic, the issuance of foreign new drugs, the suppression of science and technology semiconductors by the United States, science and technology and medicine have fallen back one after another, and Liu Chongcang's series of funds for science and technology and medicine have fallen sharply. From the past six months, when it fell the most, it underperformed the Shanghai and Shenzhen 300 in the same period, and the recent rebound barely won.
3. Any fund will inevitably fluctuate, but an excellent fund manager or high-quality fund can always be keenly aware of the advance layout and enjoy most of the gains and losses, and make certain preparations in the early stage of the callback to minimize the decline and control the retracement. This is the fundamental reason why high-quality funds have always outperformed their peers.
4, do not blindly follow, do not blindly follow, do not blindly follow. Whether the fund goes up or down. We should find out what the reason is, instead of being surprised by its rise and afraid of its decline.
5. Overall, the historical performance of funds managed by Liu is still relatively good, but recently, due to some external influences and excessive growth, the performance has fallen sharply. The overall style of the fund should not change much. Personally, I feel that the scale of his current fund should not be changed by himself if he wants to change his style. It may be decided by the company after consultation.
6. In a word. Those who are optimistic about the future of science and technology and medicine can be cautious, and those who are not optimistic about these two can stay away directly.